What Inkef does

Inkef Capital B.V. is a privately held Dutch early-stage venture capital firm headquartered in Amsterdam, founded in 2010 and operating as an independent entity under Dutch law. The firm invests in European technology and healthcare companies, positioning itself as a hands-on investor that helps build companies with a long-term strategic vision rather than relying on passive capital deployment. Inkef's stated focus spans early-stage rounds across multiple sectors, including fintech, quantum computing, biotech, medical devices, enterprise software, and consumer technology.

The firm maintains a broad portfolio of more than 40 named companies, with notable investments including GitLab, Remote, Silverflow, Quantum Motion, Salvia BioElectronics, Cardior, Audion Therapeutics, Aidence, Castor, EclecticIQ, and Wercker (acquired by Oracle). Recent activity includes participation in Silverflow's $40M Series B in March 2026 and Quantum Motion's $160M Series C in 2025, demonstrating active follow-on capital deployment. The team comprises five partners (Corné Jansen, Frank Lansink, Thijs Cohen Tervaert, Ivan Burkov, Ryan Sarver), one senior associate, and dedicated finance, risk, and marketing leadership, consistent with the stated 11–50 employee range.

Inkef generates revenue through conventional venture capital mechanics — management fees on funds under management and carried interest on successful exits — while complying with EU SFDR sustainability disclosure requirements. The firm acquires deal flow through direct outreach, partner networks, and industry relationships across European geographies, and primarily communicates with the market via LinkedIn. No public revenue, AUM, or fund-size disclosures are available in the input data, and no parent company, subsidiaries, or public listing are reported.

Name

Inkef

Legal name

INKEF Capital B.V.

Website

https://inkef.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

Inkef Capital is a Dutch early-stage venture capital firm headquartered in Amsterdam, investing across European technology and healthcare with a hands-on, long-term approach. Its diversified portfolio spans fintech, quantum computing, biotech, medtech, enterprise software, and consumer technology.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Management, Scientific, and Technical Consulting Services (5416)

SIC

Investment Advice (6282)

akta.pro primary industry

Micro-VC & Angel Funds (FSANAAAI)

akta.pro secondary industry

Accelerators & Incubators (Investor-Operated) (FSANAAAM)

Keywords

• Early-stage venture capital
• Technology investments
• Healthcare investments
• European startups
• Seed funding

Headquarters

HQ city

Amsterdam

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D

Revenue model

1. Investment Returns: Generates returns through equity investments in early-stage companies, with value creation through hands-on involvement and long-term strategic vision.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Inkef is an early-stage venture capital firm that provides equity capital and hands-on operational support to European technology and healthcare startups. The firm invests across sectors including fintech, biotech, quantum computing, and enterprise software, helping build companies with a long-term strategic vision.

Product overview

Inkef is an early-stage venture capital firm that provides investment and strategic support to technology companies. Rather than offering a product platform, Inkef operates as a hands-on investor helping build companies with long-term strategic vision. The company maintains a diverse portfolio of investments across multiple sectors including fintech (Silverflow), quantum computing (Quantum Motion), biotech (Salvia BioElectronics, Cardior, Audion Therapeutics), enterprise software (GitLab, Happeo, Castor), and various other technology ventures.

Differentiator

Problem solved

Functional benefit

Products and services

• Early-Stage Venture Capital Investment

Named customers3 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Direct peers

• Atomico: London-based early-to-growth-stage European venture capital firm investing in technology companies with a hands-on, founder-focused approach. Directly comparable to Inkef as a European-focused, early-stage specialist with a similar value-add thesis and stage focus.
• Balderton Capital: London-based early-stage venture capital firm focused on European technology startups from Seed and Series A. Directly comparable as a European early-stage VC with similar stage focus and portfolio diversification across tech and consumer.
• Earlybird Venture Capital: Berlin-based European venture capital firm investing in technology and healthcare startups from seed to Series B. Directly comparable to Inkef as a European early-stage specialist with deep tech and healthcare exposure.
• Speedinvest: Vienna-based early-stage venture capital firm focused on European technology startups across fintech, deep tech, and digital health. Directly comparable to Inkef in stage focus, sector breadth, and European geographic focus.
• HV Capital: Munich-based venture capital firm investing in European internet and technology companies from seed to growth. Comparable to Inkef as a European early-stage specialist with similar fund size and stage focus.
• Notion Capital: London-based venture capital firm specializing in European enterprise SaaS and B2B technology. Comparable to Inkef in European focus and enterprise software exposure (similar to portfolio names like Happeo, Castor, EclecticIQ).
• Northzone: Stockholm-based venture capital firm investing in European and US technology startups from seed to growth. Comparable to Inkef as a European-focused early-stage VC with a similar stage mandate and sector breadth.
• LocalGlobe: London-based seed-stage venture capital firm investing in European technology startups. Comparable to Inkef in European early-stage focus, though typically at smaller initial check sizes.

Broad incumbents

• Index Ventures: Pan-European and US venture capital firm investing from seed to growth across technology and biotech. A broader incumbent relative to Inkef, with much larger fund vintages and a wider stage range, but comparable in its European early-stage technology focus.
• Accel: Global venture capital firm with strong European and US presence, investing from early to growth stage. Comparable in stage focus and European tech investing, but at a much larger scale than Inkef.

Market position

Competitive moat4 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/inkef

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments88 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Inkef